Abstract. Obesity is a growing problem and is associated with numerous medical conditions. In several genes coding for molecules involved in the regulation of body weight (fat mass) and thermogenesis, polymorphisms have been reported which possibly modify human obesity risk. The aim of this study was to determine the incidence of the following polymorphisms in the following genes in 262 obese (BMI≥30) and 138 control (BMI≤25) subjects: leptin receptor (LEPR)-Gln223Arg, B 3 -adrenergic receptor (B 3 -AR)-Trp64Arg, serotonin transporter (5-HTT)-a 44-base pair insertion/ deletion functional polymorphism in the 5-HTTLPR and insulin receptor substrate-1 (IRS-1)-Gly972Arg. Our hypothesis was that these polymorphisms would occur more frequently in the obese population. The polymorphisms were determined by polymerase chain reaction (PCR) and restriction genotyping in study population. In our results, no strong associations were observed between BMI status and these polymorphisms. Weak, though significant, association coefficients obtained with HTT and LEPR loci indicate that the genotype numbers at these loci may depend on BMI status to some extent.
OBESITY is a major health problem worldwide influenced by both genetic and environmental factors and the risk of becoming obese has a strong genetic component [1] . Since single gene defects resulting in obesity are very rare, it is likely that a combination of polymorphisms in one or more candidate genes may contribute to its development. Using this approach, many candidate genes including β3-adrenergic receptor, leptin receptor, serotonin transporter, and insulin receptor substrate-1 gene have been assessed for association with obesity in several studies [2] .
The human B 3 -AR is expressed specifically in adipose tissues, and activated in brown adipose tissues during the thermogenesis and in white adipose tissues during the lipolysis [3] . Several studies have suggested that a missense Trp64Arg mutation in the B 3 -adrenergic receptor (ADRB3) gene is involved in obesity and insulin resistance [4] [5] [6] [7] .
Leptin is an adipose-derived cytokine present in the circulation in amounts proportional to fat mass that acts to reduce food intake and increase energy expenditure thereby regulating body weight homeostasis and the weight-regulating effects of leptin are mediated through the binding and activation of the long isoform of its receptor (LEPR-b) in the hypothalamus. LEPR, has defined a novel molecular pathway for energy metabolism and regulation of body weight [8] . The Gln223Arg polymorphism in the LEPR gene has been reported to be associated with obesity phenotypes [9] [10] [11] .
5-HTT is responsible for the sodium-dependent re-uptake of serotonin from the synapse after its release from serotonergic neurons [12] and plays a key role in regulating synapse levels of available serotonin and serotonin turnover [13] . The human 5-HTT gene has a functional polymorphism in the 5'-flanking promoter region that is described: a 44-base pair (bp) insertion/ deletion in the 5-HTT gene-linked polymorphic region (5-HTTLPR; two alleles: "long" [l] and "short" [s]) [14, 15] . The transcriptional activity of the long form allele was more than twice as high as that of the short form allele [16] . As far as we know, four studies have examined the association between 5-HTTLPR and eating disorders (ED) [17] [18] [19] [20] . The insulin receptor is part of a transmembrane tyrosine kinase-mediating intracellular signaling process that leads to the biological actions of insulin [21] . Arg972Gly, a common variant of IRS-1 gene are associated with obesity and type 2 diabetes in some populations. In obese adults, Arg972Gly appears to increase insulin resistance in its heterozygous form [22] .
Since these findings strongly suggest the existence of an interaction between leptin receptor (LEPR)-Gln223Arg, B 3 -adrenergic receptor (B 3 -AR)-Trp64Arg, serotonin transporter (5-HTT)-a 44-base pair insertion/ deletion functional polymorphisms and obesity, we compared the prevalence of these changes in obese subjects and a group of lean subjects in Turkish population.
Material and Methods
Subjects 262 obese subjects, (159 female and 103 male) (BMI; 39.0722 ± 0.3586) and 138 control subjects (55 female and 84 male) (BMI; 21.7391 ± 0.1897) were enrolled into the study. The obese subjects were recruited from the outpatient clinic of Department of Endocrinology and Metabolism of Gülhane Military School of Medicine in Turkey. Body mass index (BMI) values were greater than 30 kg/m 2 in obese subjects. All obese subjects had a history of severe obesity before the age of 10 and had at least one other obese family member. None of the obese subjects had diabetes mellitus or impaired glucose tolerance in this study. Control subjects underwent routine physical and laboratory evaluations to ensure that none had obesity, diabetes mellitus, hyperlipidemia, psychiatric, metabolic, hepatic or renal disease. None of the control subjects had a family history of hyperlipidemia or diabetes. The study was approved by the local ethical committee of Gülhane Medical School.
DNA studies
Genomic DNA was extracted from white blood cells using phenol-chloroform extraction. The Trp64Arg of ADRB3 gene, Gln223Arg of LEPR gene and Gly972Arg of IRS-1 gene polymorphisms were determined by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) using BstN I, Msp I and Sma I endonuclease enzymes digestion, respectively, according to the methods described in the literature [4, 6, 23, 24] . The 5-HTTLPR genotype was determined by the method of Lesch et al. [25] .
Statistical analysis
All the statistical analysis was performed with SPSS 10.0 (SPSS Inc., Chicago, IL, USA) statistical package. Body mass indices of obese and lean subjects were analyzed on genotypic grounds by single classification ANOVA. Since the test chosen (Levene's Test) for the homoscedasticity of the group variances showed significant heterogeneity among the studied groups, a post hoc test that does not assume variance equality, Games-Howell, was performed in the analyses [26] . Allelic differences were tested using a χ 2 which uses the weighted variance and weighted average of allele frequencies over the samples compared [27] . In this analysis female and male genotypes were pooled as there were no significant sex differences in obesity on genotypic grounds (not shown).
Results
Mean BMI values of lean and obese samples were estimated. A t-test was performed for assessing significancy of the difference between them. Individual BMI values were logarithmically transformed for normality and variance homogeneity because the nontransformed original measurements of the two groups were not distributed normally and had nonhomogenous variances (not shown). The t-test was the one appropriate for the unequal sample sizes with a large difference [26] . A t-test shows the expected highly significant difference between lean and obese samples with re-spect to BMI (t = 14.936, d.f. = 120, P<0.001). Estimated allele frequencies and relevant statistics are shown in Table 1 . Deviations from Hardy-Weinberg equilibriums were tested using conventional χ 2 test with categories having expected genotype numbers less than 5 added to second largest category (i.e., ADBR3 and IRS). Only LEPR locus of obese sample showed significant deviation from Hardy-Weinberg equilibrium (χ 2 = 5.31, d.f. = 1, P<0.05, Table 1 ). This significant deviation at LEPR is due to higher frequency of the mutant allele (Arg223 = 0.380) in the obese sample. Allele frequency differences between lean and obese samples were also tested for significancy. The test performed was the one by Workman and Niswander (1970) [27] , in which weighted average variance of allele frequencies between any two samples is used to obtain a χ 2 test value. HTT and LEPR normal allele frequencies seem to be significantly different between lean and obese samples (χ 2 = 5.58 (HTT) and χ 2 = 4.19 (LEPR), d.f. = 1, P<0.05). This is due to a higher frequency of the mutant allele in the obese sample in both cases (L = 0.494 and Arg223 = 0.380, respectively). As there was no significant allele frequency difference between sexes per loci (not shown) sex-pooled numbers were used in the tests. Whether there was an association of genotype numbers at HTT and LEPR loci with obesity was tested by an R × C test of independence in a 3 (genotypes) × 2 (BMI statuses as lean and obese) design (see Sokal and Rohlf, 1995, p. 738, for details) [26] . G-values obtained by the test and the phi (Φ) coefficients of association for each genotype are shown in Table 2 . Although estimated G-values (i.e., associated χ 2 values for d.f. = (3-1) × (2-1) = 2) are not significant, they are quite close to the border of significant deviation (i.e., tabled χ 2 = 5.991, d.f. = 2, P = 0.05). Association coefficients indicate that the genotype numbers at HTT and LEPR loci may depend on BMI status, though not strongly. To see whether genotypic combinations of alleles may affect obesity level, we performed analyses in the obese group using genotype specific BMI values for all the loci (i.e. HTT, LEPR, ADBR3, and IRS). In that respect, one-way ANOVAs were performed for each loci in which BMI was dependent variable and genotypes for a locus were treated as groups. Table 3 gives the descriptive data and statistical assesments for mean BMI differences among genotypes within particular loci. For the 5-HTT and LEPR loci, mean BMIs among the genotypes were not significantly different. For the ADBR3 locus, genotype based mean BMIs were estimated only for the Ttrp64Trp homozygote and Trp64Arg heterozygote as there was only one Arg64Arg homozygote individual found in our study. The mean BMI difference between the Trp64Trp homozygote and Trp64Arg heterozygote was significant (F = 0.013, P<0.05, Table 3 ). As for the IRS-1, only two genotypic categories (Gly972Gln and Gly972Arg) existed, the difference between respective BMIs being not significant this time (F = 0.121, Table 3 ). The striking similarity between ADBR3 and IRS-1 is that when the common allele (i.e. Trp64 and Gly972, respectively) is halved in number in heterozygotes, there seems a dose affect raising the mean BMI values (Mean BMIs of ADBR3 and IRS-1 heterozygotes, Table 3 ). But the small number of heterozygotes available for the each locus and the large standard errors for heterozygote BMIs (Table 3 , SE) ensuing make it more likely a sampling effect stemming from the rarity of the mutant alleles in the respective loci (Arg64 in ADBR3 and Arg972 in IRS-1, Table 1 ).
Discussion
In this study we investigated the effects of four common polymorphisms in the 5-HTT, LEPR, ADBR3 and IRS-1 genes, namely the 5-HTTLPR, Q223R, Trp64Arg and Gly972Arg polymorphisms, on BMI in a Turkish obese and lean individuals. Although no association between BMI status and these polymorphism was observed, there was a weak, but significant, association coefficients indicating that the genotype numbers at HTT and LEPR loci may depend on BMI status, though not strongly (Table 1, 2) . Similarly, no significant effect on gender on body mass indices was detected within each genotype or among the different genotypes in this study (data not shown). We also performed analyses in the obese group using genotype specific BMI values for all the loci (i.e. HTT, LEPR, ADBR3, and IRS) to see whether genotypic combinations of alleles may affect obesity level. Though, in halving the number of common alleles, there seems a dose affect raising the mean BMI values in two of the loci (ADBR3 and IRS-1 heterozygotes, Table 3 ), small number of heterozygotes available for the each locus and the large standard errors for heterozygote BMIs ensuing make it more likely a sampling effect stemming from the rarity of the mutant alleles in the respective loci.
Overall, these findings are in accordance with recent studies in which no difference has been found in the allelic frequencies of the LEPR and ADBR3 genes polymorphisms between obese and nonobese subjects. For example, linkage analysis in the Quebec Family Study Cohort has indicated no association of the Arg allele with obesity-related phenotypes [28] . Silver et al. have shown that Gln223Arg polymorphism in the human leptin receptor do not associate with traits related to obesity [29] .
Obesity is a major public health concern given the association of this condition with several chronic diseases. Identification of genetic variants that increase a person's susceptibility to the common forms of obesity is a critical problem. Several recent studies have made an attempt in this direction. Studies in Pima Indians [4] , French Caucasians [5] , Finns [6] , Japanese [7] have shown of a modest association of the Arg allele with various anthropometric markers of obesity and diabetes.
Several studies have suggested that a common polymorphism Gln223Arg in the LEPR gene is associated with obesity phenotypes. For example, this association was observed in middle-aged Caucasian males [9] , postmenopausal Caucasian women [10] , a Mediterranean population [11] . As far as we know, four studies have examined the association between 5-HTTLPR and ED. Fumeron et al. reported a higher frequency of the S/S genotype of 5-HTTLPR in AN subjects than in normal-weight controls [17] , but reports of evidence against these findings [18] [19] [20] make the association controversial.
Mutations in the IRS-1 gene are associated with obesity and type 2 diabetes in some populations. In obese adults, however, Arg972Gly appears to increase insulin resistance in its heterozygous form [22] .
We know that the confounding factor of the several studies may be due to a small size of study groups and ethnic differences of them. It must be noted, however, our analyses were carried out on randomly chosen samples in terms of ethnic origin, hence no different ethnic compositions in the case and control samples (Turkish population). Though the correlation profile of B3-AR and IRS-1 may be due to relatively small sample size, we think that this situation could also arise from different contributions of different polymorphisms to BMI status. On the other hand, in the obesity panel, the subjects were obese before the age of ten. This might arise the possibility that they may have very strong genetic background, and that the effects of the polymorphisms we examined may have been masked. Those polymorphisms may contribute to milder form of obesity in Turkish population.
In conclusion, our study does not provide evidence for a major role of the 5-HTT, LEPR, ADBR3 and IRS-1 genes, namely the 5-HTTLPR, Q223R, Trp64Arg and Gly972Arg polymorphisms, in predisposition to obesity. As our knowledge of obesity genes advances with new discoveries, further studies of well defined obesity phenotypes and associated gene mutations or polymorphisms in larger samples may be helpful to investigate a more subtle effect of these genes in this serious phenotype. Such studies should also consider possible interactions with other genetic polymorphisms.
